Title: 2025-2026 Regular Session HR 157 PN 1186 Bill Text (HTM)
Official Title: 
Number of Sections: 1
Source: versions - Printer's No. PN1186
Media Type: text/html

================================================================================

Section 1:
2025-2026 Regular Session HR 157 PN 1186 Bill Text (HTM) See other bills under thesame topic PRINTER'S NO. 1186 THE GENERAL ASSEMBLY OF PENNSYLVANIAHOUSE RESOLUTION No.157 Session of 2025 INTRODUCED BY ZIMMERMAN, KRUPA, HAMM, FREEMAN, GUENST, JAMES, SCHEUREN, HADDOCK, NEILSON, SCHMITT, COOK, GILLEN AND K.HARRIS, MARCH 31, 2025 REFERRED TO COMMITTEE ON INTERGOVERNMENTAL AFFAIRS AND OPERATIONS, MARCH 31, 2025 A RESOLUTIONUrging the Congress of the United States to pass H.R. 3023, the Treatment and Relief through Emerging and Accessible Therapy for PTSD Act, should it be reintroduced, or similar legislation dealing with stellate ganglion block therapy to veterans and members of the armed forces of the United States with post-traumatic stress disorder, during the 119th United States Congress.WHEREAS, H.R. 3023 directs the United States Secretary of Veterans Affairs and the United States Secretary of Defense to furnish stellate ganglion block (SGB) therapy to veterans and members of the armed forces of the United States with post-traumatic stress disorder (PTSD); andWHEREAS, The United States Department of Veterans Affairs (VA) estimates that 23% of Operation Enduring Freedom and Operation Iraqi Freedom veterans have received a diagnosis of PTSD; andWHEREAS, Older veterans are also impacted, with the VA estimating that 12% of Gulf War veterans and 15% of Vietnam veterans receive a PTSD diagnosis each year; and12345678910111213141516171819 WHEREAS, Unfortunately, only 40% of veterans find relief from PTSD with current treatments; andWHEREAS, If left untreated, PTSD symptoms have a positive correlation with suicide risk; andWHEREAS, The lack of effective PTSD treatments directly contributes to the 20 veteran suicides the United States experiences each day; andWHEREAS, An SGB procedure injects an anesthetic agent on the stellate ganglion, a collection of nerves in the neck that controls the activation of the "fight" or "flight" survival reflex; andWHEREAS, SGB is proven to alleviate common PTSD symptoms such as hyperarousal, exaggerated startle responses and anxiety; andWHEREAS, The procedure has been performed since the 1920s and is considered low risk; andWHEREAS, SGB was first recognized as a treatment for PTSD in 2008; andWHEREAS, H.R. 3023 is supported by the Pennsylvania National Guard Associations, the American Legion and behavioral health clinicians; therefore be itRESOLVED, That the House of Representatives of the Commonwealth of Pennsylvania urge the Congress of the United States to pass H.R. 3023, the Treatment and Relief through Emerging and Accessible Therapy for PTSD Act, should it be reintroduced, or similar legislation dealing with stellate ganglion block therapy to veterans and members of the armed forces of the United States with post-traumatic stress disorder, during the 119th United States Congress; and be it furtherRESOLVED, That copies of this resolution be transmitted to the President of the United States, the presiding officers of 20250HR0157PN1186 - 2 - 123456789101112131415161718192021222324252627282930 each house of Congress and to each member of Congress from Pennsylvania.20250HR0157PN1186 - 3 - 12


================================================================================

Raw Text:
2025-2026 Regular Session HR 157 PN 1186 Bill Text (HTM) See other bills under thesame topic PRINTER'S NO. 1186 THE GENERAL ASSEMBLY OF PENNSYLVANIAHOUSE RESOLUTION No.157 Session of 2025 INTRODUCED BY ZIMMERMAN, KRUPA, HAMM, FREEMAN, GUENST, JAMES, SCHEUREN, HADDOCK, NEILSON, SCHMITT, COOK, GILLEN AND K.HARRIS, MARCH 31, 2025 REFERRED TO COMMITTEE ON INTERGOVERNMENTAL AFFAIRS AND OPERATIONS, MARCH 31, 2025 A RESOLUTIONUrging the Congress of the United States to pass H.R. 3023, the Treatment and Relief through Emerging and Accessible Therapy for PTSD Act, should it be reintroduced, or similar legislation dealing with stellate ganglion block therapy to veterans and members of the armed forces of the United States with post-traumatic stress disorder, during the 119th United States Congress.WHEREAS, H.R. 3023 directs the United States Secretary of Veterans Affairs and the United States Secretary of Defense to furnish stellate ganglion block (SGB) therapy to veterans and members of the armed forces of the United States with post-traumatic stress disorder (PTSD); andWHEREAS, The United States Department of Veterans Affairs (VA) estimates that 23% of Operation Enduring Freedom and Operation Iraqi Freedom veterans have received a diagnosis of PTSD; andWHEREAS, Older veterans are also impacted, with the VA estimating that 12% of Gulf War veterans and 15% of Vietnam veterans receive a PTSD diagnosis each year; and12345678910111213141516171819 WHEREAS, Unfortunately, only 40% of veterans find relief from PTSD with current treatments; andWHEREAS, If left untreated, PTSD symptoms have a positive correlation with suicide risk; andWHEREAS, The lack of effective PTSD treatments directly contributes to the 20 veteran suicides the United States experiences each day; andWHEREAS, An SGB procedure injects an anesthetic agent on the stellate ganglion, a collection of nerves in the neck that controls the activation of the "fight" or "flight" survival reflex; andWHEREAS, SGB is proven to alleviate common PTSD symptoms such as hyperarousal, exaggerated startle responses and anxiety; andWHEREAS, The procedure has been performed since the 1920s and is considered low risk; andWHEREAS, SGB was first recognized as a treatment for PTSD in 2008; andWHEREAS, H.R. 3023 is supported by the Pennsylvania National Guard Associations, the American Legion and behavioral health clinicians; therefore be itRESOLVED, That the House of Representatives of the Commonwealth of Pennsylvania urge the Congress of the United States to pass H.R. 3023, the Treatment and Relief through Emerging and Accessible Therapy for PTSD Act, should it be reintroduced, or similar legislation dealing with stellate ganglion block therapy to veterans and members of the armed forces of the United States with post-traumatic stress disorder, during the 119th United States Congress; and be it furtherRESOLVED, That copies of this resolution be transmitted to the President of the United States, the presiding officers of 20250HR0157PN1186 - 2 - 123456789101112131415161718192021222324252627282930 each house of Congress and to each member of Congress from Pennsylvania.20250HR0157PN1186 - 3 - 12